(Edited) RPG Life Science calms down investors. Says media writings are premature

(Edited: details about what the Exchange had advised RPG to do)

RPG Life Science Limited has said that the media reports which said that “RPG Life Plans Skincare Foray, May Roll Out Biz Next Month” came out premature.

RPG said Friday that the Exchange, in order to verify the accuracy of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

The Exchange has advised the RPG to clarify or confirmon the news item in detail.

The Exchange wanted to be known whether such negotiations were taking place and whether RPG is aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading.

The response from the company came shortly after.

However, RPG’s responded in a mild tone. It didn’t deny the media writings, but rather said that the news appeared were premature.

The company said it was “in the midst of developing the long term strategy.”

Does that indicate – with the news being ‘premature’ – that changes might happen?

This is RPG’s response to the Exchange:

“We wish to inform you that the company is in the midst of developing the long term strategy and the news appeared is premature.”

“In case of any material event or price sensitive information, the company shall immediately inform the exchange as required under clause 36 of the Listing Agreement.”